Tenax Therapeutics (TENX) Gross Margin (2010 - 2013)
Tenax Therapeutics recorded quarterly Gross Margin of 20.52% in Q2 2013, up 3291.96% quarter-over-quarter from 0.6% in Q1 2013, and up 1462.0% year-over-year from 1.31% in Q2 2012.
Tenax Therapeutics' Gross Margin history runs 4 years deep, the most recent figure standing at 20.52% for Q2 2013.
- In Q2 2013, Gross Margin rose 1462.0% year-over-year to 20.52%; the TTM figure through Dec 2015 stood at 19.07% (changed N/A YoY), while the FY2014 annual figure was 39.57%, down 4373.0% from the prior year.
- Gross Margin came in at 20.52% for Q2 2013 at Tenax Therapeutics, up from 0.6% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q4 2010 to a low of 0.6% in Q1 2013.
- A 4-year average of 40.85% and a median of 17.78% in 2011 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 9852 bps in 2012 and jumped 1462 bps in 2013, its largest moves.
- Tenax Therapeutics' Gross Margin stood at 100.0% in 2010, then plunged by 82 bps to 17.78% in 2011, then sank by 94 bps to 1.06% in 2012, then jumped by 1843 bps to 20.52% in 2013.
- According to Business Quant data, Gross Margin over the past three periods registered 20.52%, 0.6%, and 1.06% for Q2 2013, Q1 2013, and Q4 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 20.52% |
| Jan 31, 2013 | 0.60% |
| Oct 31, 2012 | 1.06% |
| Jul 31, 2012 | 2.04% |
| Apr 30, 2012 | 5.90% |
| Jan 31, 2012 | 1.48% |
| Oct 31, 2011 | 17.78% |
| Jul 31, 2011 | 100.00% |
| Apr 30, 2011 | 100.00% |
| Jan 31, 2011 | 100.00% |
| Oct 31, 2010 | 100.00% |